NGAL AS A MARKER FOR THE EFFICIENCY OF PERCUTANEOUS CORONARY INTERVENTION


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The authors studied the prognostic value of the concurrent use of the GRACE scale and serum neutrophil gelatinase-associated lipocalin (NGAL) estimated during hospital stay in ST-elevation myocardial infarction patients who had undergone percutaneous coronary intervention.

全文:

受限制的访问

作者简介

M. Zykov

Research Institute for Complex Problems of Cardiovascular Diseases

Email: mvz83@mail.ru
Candidate of Medical Sciences

V. Kashtalap

Research Institute for Complex Problems of Cardiovascular Diseases; Kemerovo State Medical Academy

I. Bykova

Research Institute for Complex Problems of Cardiovascular Diseases

Candidate of Medical Sciences

V. Kalaeva

Research Institute for Complex Problems of Cardiovascular Diseases

O. Khryachkova

Research Institute for Complex Problems of Cardiovascular Diseases

V. Karetnikova

Research Institute for Complex Problems of Cardiovascular Diseases; Kemerovo State Medical Academy

Professor

O. Barbarash

Research Institute for Complex Problems of Cardiovascular Diseases; Kemerovo State Medical Academy

Professor

参考

  1. The 10 leading causes of death in the world, 2000 and 2011, Fact sheet № 310 of WHO. Режим доступа: http://www.who.int/mediacentre/factsheets/fs310/en/index.html
  2. Самородская И.В. Острые формы ишемической болезни сердца: необходимость решения проблемы сопоставимости данных о распространенности и летальности // Болезни сердца и сосудов. - 2010; 1: 25-8.
  3. Алекян Б.Г., Абросимов А.В. Современное состояние рентгенэндоваскулярного лечения острого коронарного синдрома и перспективы его развития в Российской Федерации // Комплексные проблемы сердечно-сосудистых заболеваний. - 2013; 1: 5-9.
  4. Baber U., Stone G., Weisz G. et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes // JACC Cardiovasc. Imaging. - 2012; 5: 53-61.
  5. Bawamia B., Mehran R., Qiu W. et al. Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review // Am. Heart J. - 2013; 165 (4): 441-50.
  6. Шафранская К.С., Кашталап В.В., Баздырев Е.Д. и др. Возможности диагностики острого повреждения почек с использованием липокалина, ассоциированного с желатиназой нейтрофилов (NGAL) в кардиологии (обзор литературы) // Сиб. мед. журн. - 2011; 26 (4, вып. 1): 15-9.
  7. Shen S., Hu Z., Li Q. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease // Nephrology (Carlton). - 2014; 19 (3): 29-35.
  8. Zografos T., Haliassos A., Korovesis S. et al. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease // Am. J. Cardiol. - 2009; 104: 917-20.
  9. Palmerini T., Genereux P., Caixeta A. et al. A New Score for Risk Stratification of Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) Risk Score // JACC. - 2012; 5: 1108-16.
  10. Saltzman A., Stone G., Claessen B. et al. Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention // JACC. - 2011; 4: 1011-9.
  11. Keeley E., Boura J., Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials // Lancet. - 2003; 361 (9351): 13-20.
  12. Hemdahl A., Gabrielsen A., Zhu C. et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction // Arterioscler. Thromb. Vasc. Biol. - 2006; 26 (1): 136-42.
  13. Zografos T., Haliassos A., Korovesis S. et al. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease // Am. J. Cardiol. - 2009; 104: 917-20.
  14. Choi K., Lee J., Kim E. et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease // Eur. J. Endocrinol. - 2008; 158: 203-7.
  15. Haase M., Bellomo R., Devarjan P. et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults // Ann. Thorac. Surg. - 2009; 88: 124-30.
  16. Mishra J., Ma Q., Prada A. et al. Identification of neutrophil gelatinaseassociated lipocalin as a novel early biomarker for ischemic renal injury // J. Am. Soc. Nephrol. - 2003; 14: 2534-43.
  17. Alvelos M., Lourenço Р., Dias C. et al. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure // Int. J. Cardiol. - 2013; 165: 51-5.
  18. Shrestha K., Shao Z., Singh D. et al. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure // Am. J. Cardiol. - 2012; 110: 1329-35.
  19. Torregrosa I., Montoliu С., Urios А. et al. Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure // Nefrologia. - 2012; 32: 44-52.
  20. Cruz D., Gaiao S., Maisel A. et al. Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review // Clin. Chem. Lab. Med. - 2012; 50: 1533-45.
  21. Lindberg S., Jensen J., Mogelvang R. et al. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis // Arterioscler. Thromb. Vasc. Biol. - 2014; 34 (9): 2135-42.
  22. Daniels L., Barrett-Connor E., Clopton P. et al. Plasma Neutrophil Gelatinase-Associated Lipocalin Is Independently Associated With Cardiovascular Disease and Mortality in Community-Dwelling Older Adults // J. Am. Coll. Cardiol. - 2012; 59 (12): 1101-9.
  23. Lindberg S., Pedersen S., Mogelvang R. et al. Prognostic Utility of Neutrophil Gelatinase-Associated Lipocalin in Predicting Mortality and Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention // JACC. - 2012; 60: 339-45.
  24. Bachorzewska-Gajewska H., Tomaszuk-Kazberuk A., Jarocka I. et al. Does neutrophil Gelatinase-Asociated Lipocalin Have Prognostic Value in Patients with Stable Angina Undergoing Elective PCI? A 3-Year Follow-Up Study // Kidney Blood Press Res. - 2013; 37: 280-5.
  25. Lin H., Hwang D., Lee S. et al. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients // Clin. Chem. Lab. Med. - 2015; 53 (1): 73-83.
  26. Зыков М.В., Кашталап В.В., Зыкова Д.С. и др. Прогнозирование осложнений инфаркта миокарда в течение одного года наблюдения // Сиб. мед. журн. - 2011; 26 (4-1): 41-6.
  27. Lev E., Kornowski R., Vaknin-Assa H. et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention // Am. J. Cardiol. - 2008; 102: 6-11.
  28. Abu-Assi E., Ferreira-Gonzalez I., Ribera A. et al. Do GRACE (Global Registry of Acute Coronary Events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes? // Am. Heart J. - 2010; 160 (5): 826-34.
  29. Mendez-Eirin E., Flores-Rios X., Garcia-Lopez F. et al. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI // Rev. Esp. Cardiol. - 2012; 65: 227-33.
  30. Климкин П.Ф. Прогнозирование течения острого коронарного синдрома в зависимости от уровня некоторых маркеров острого повреждения почек в различных биологических средах. Автореф. дис.. канд. мед. наук. Нижний Новгород, 2014.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Russkiy Vrach Publishing House, 2015
##common.cookie##